Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa pilot trial of XCEL-MT-OSTEO-ALPHA for non-hypertrophic pseudarthrosis of long bones
2013-005025-23Phase 2Completed
- Sponsor
- Banc de Sang i Teixits
- Start
- Jan 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of XCEL-MT-OSTEO-ALPHA in Pseudarthrosis of long bone (2 arms), sponsored by Banc de Sang i Teixits. Primary endpoint: Efficacy assessment by CT. Started Jan 2014; status: completed.
02
Drugs
XCEL-MT-OSTEO-ALPHA
03
Conditions
Pseudarthrosis of long bone
Beyond the preview
Go deeper on 2013-005025-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005025-23.